Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome — Experience in 300 patients

Transplantation

Volumn 51, Issue 2, 1991, Pages 428-430

  Gonwa, Thomas A ^a   Morris, Christine A ^a   Goldstein, Robert M ^a   Husberg, Bo S ^a   Klintmalm, Goran B ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CONFERENCE PAPER; FEMALE; HEPATORENAL SYNDROME; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL;

CREATININE; CYCLOSPORINS; FEMALE; GLOMERULAR FILTRATION RATE; HEPATORENAL SYNDROME; HUMAN; KIDNEY; LIVER TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0026096518     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199102000-00030     Document Type: Article

References (25)

1. Iwatsuki S, Popovtzer MM, Corman JL, et al. Recovery from “hepatorenal syndrome” after orthotopic liver transplantation. N Engl J Med 1973; 289: 1155.
2. Wood RP, Ellis D, Starzl TE. The reversal of the hepatorenal syndrome in four pediatric patients following successful orthotopic liver transplantation. Ann Surg 1987; 205: 415.
3. Gonwa TA, Poplawski S, Paulsen W, et al. Pathogenesis and outcome of hepatorenal syndrome in patients undergoing orthotopic liver transplant. Transplantation 1989; 47: 395.
4. Poplawski SC, Gonwa TA, Goldstein RM, et al. Renal dysfunction following orthotopic liver transplantation. Clin Transplant 1989; 3: 94.
5. Klintmalm GBG, Iwatsuki S, Starzl TE. Nephrotoxicity of cyclosporine A in liver and kidney transplant patients. Lancet 1981; 2: 470.
6. Powell-Jackson PR, Young B, Caine RY, et al. Nephrotoxicity of parenterally administered cyclosporine after orthotopic liver transplants. Transplantation 1983; 36: 505.
7. Grady JG, Forbes A, Rolles A, et al. An analysis of cyclosporine efficacy and toxicity after liver transplantation. Transplantation 1988; 45: 575.
8. Wheateley HC, Datgam M, Williams JE, et al. Long-term effects of cyclosporine on renal function in liver transplant recipients. Transplantation 1987; 43: 641.
9. Klintmalm GBG, Nery J, Husberg B, et al. Rejection in liver transplantation. Hepatology 1989; 40: 978.
10. Israelite AH, Long DL, White MG, et al. Measurement of glomerular filtration rate utilizing a simple subcutaneous injection of I125-iothalamate. Kidney Int 1973; 4: 346.
11. Epstein M. In: Epstein M, ed. Hepatorenal syndrome. Baltimore; Williams & Wilkins, 1988: 89.
12. Myers BD, Ross J, Newton L, et al. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984; 311: 699.
13. Myers BD, Sibley R, Newton L, et al. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988; 33: 590.
14. Myers BD, Newton L, Boshkas C, et al. Chronic injury of humanrenal microvessels with low-dose cyclosporine therapy. Transplantation 1988; 46: 694.
15. Tomlanovich S, Golbetz H, Perloth M, et al. Limitations of creat inine in quantifying the severity of cyclosporine-induced chronic nephropathy. Am J Kidney Dis 1986; 8: 332.
16. Ring-Larsen H, Henriksen JH. Pathogenesis of ascites formation and hepatorenal syndrome: humoral and hemodynamic factors. Semin Liver Dis 1986; 6: 341.
17. Lenz K, Hortnagel H, Magometshnigg D, et al. Function of the autonomic nervous system in patients with hepatic encephalopathy. Hepatology 1985; 5: 831.
18. Willet I, Esler M, Burke F, et al. Total and renal sympatheti cnervous system activity in alcoholic cirrhosis. J Hepatol 1985; 1: 634.
19. Moss NG, Powell SL, Falk RJ. Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci USA 1985; 82: 8222.
20. Murray BM, Poller MS, Ferris TF. Effect of cyclosporine administration on renal hemodynamics in conscious rats. Kidney Int 1985; 28: 767.
21. Solis-Herruzo JA, Duran A, Favela V, et al. Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome. J Hepatol 1987; 5: 167.
22. Gonwa TA, Poplawski SC, Husberg BS, et al. Cyclosporine nephrotoxicity in orthotopic liver transplantation. Transplant Proc 1988; 20: 401.
23. Millis JM, Baquerigo A, Saleh S, Danovitch GM, Busuttil RW. Preservation of renal function using OKT3 in liver transplant patients. Transplant Proc 1989; 21: 3551.
24. Pinzcani M, Zipser RD. The hepatorenal syndrome. Intensive Care Med 1987; 13: 148.
25. Dibona GF. Renal neural activity in hepatorenal syndrome. Kidney Int 1984; 25: 841.